MERCK KGAA O.N. | 103.100 / -0.10% |
Date/Time | 12/10 / 11:43 |
Chg. / Chg.(%) | -0.100 / -0.10% |
Bid | 103.000 / 114 |
Ask | 103.050 / 114 |
Open | 103.200 |
Previous Close | 103.200 |
High | 103.200 |
Low | 103.100 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 4 |
ISIN | DE0006599905 |
Security | MRK |
Exchange | gettex |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 102.86 | ![]() |
198,893 |
Xetra | 103.15 | ![]() |
134,470 |
Cboe Europe .. | 103.15 | ![]() |
29,489 |
Cboe Europe .. | 103.15 | ![]() |
10,569 |
Turquoise | 103.05 | ![]() |
7,822 |
TradeGate | 103.200 | ![]() |
1,884 |
Stuttgart | 103.100 | ![]() |
710 |
Frankfurt | 103.2000 | ![]() |
589 |
Vienna Globa.. | 103.00 | ![]() |
0 |
Hamburg | 102.80 | ![]() |
0 |
Düsseldorf | 103.30 | ![]() |
0 |
München | 103.00 | ![]() |
0 |
Hannover | 102.80 | ![]() |
0 |
Berlin | 102.90 | ![]() |
0 |
Lang & Schwa.. | 103.100 | ![]() |
|
gettex | 103.100 | ![]() |
|
Borsa Italia.. | 103.65 | 78 | |
Nasdaq Other.. | 113.2000 | ![]() |
40 |
SIX Swiss Ex.. | 102.20 | ||
SIX Swiss Ex.. | 97.00 | ||
EUREX | Options |
News
- Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD
10:00 - GlobeNewswire - Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader
Personal area
Click on
to activate push quotes.
